Advanced glycation end-products disrupt brain microvascular endothelial cell barrier: The role of mitochondria and oxidative stress.


Journal

Microvascular research
ISSN: 1095-9319
Titre abrégé: Microvasc Res
Pays: United States
ID NLM: 0165035

Informations de publication

Date de publication:
01 2021
Historique:
received: 28 07 2020
revised: 06 10 2020
accepted: 14 10 2020
pubmed: 20 10 2020
medline: 18 2 2021
entrez: 19 10 2020
Statut: ppublish

Résumé

During diabetes mellitus, advanced glycation end-products (AGEs) are major contributors to the development of alterations in cerebral capillaries, leading to the disruption of the blood-brain barrier (BBB). Consequently, this is often associated with an amplified oxidative stress response in microvascular endothelial cells. As a model to mimic brain microvasculature, the bEnd.3 endothelial cell line was used to investigate cell barrier function. Cells were exposed to native bovine serum albumin (BSA) or modified BSA (BSA-AGEs). In the presence or absence of the antioxidant compound, N-acetyl-cysteine, cell permeability was assessed by FITC-dextran exclusion, intracellular free radical formation was monitored with H

Identifiants

pubmed: 33075405
pii: S0026-2862(20)30158-8
doi: 10.1016/j.mvr.2020.104098
pmc: PMC8782206
mid: NIHMS1657071
pii:
doi:

Substances chimiques

Glycation End Products, Advanced 0
Reactive Oxygen Species 0
advanced glycation end products-bovine serum albumin 0
Serum Albumin, Bovine 27432CM55Q

Types de publication

Journal Article Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

104098

Subventions

Organisme : Intramural NIH HHS
ID : Z01 ES021164
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Références

Free Radic Biol Med. 2011 Nov 1;51(9):1621-35
pubmed: 21872656
Curr Eye Res. 2005 Apr;30(4):279-90
pubmed: 16020258
J Diabetes Investig. 2012 Oct 18;3(5):413-23
pubmed: 24843599
Free Radic Biol Med. 2010 Mar 15;48(6):781-90
pubmed: 20036735
Stroke. 2015 Jun;46(6):1681-9
pubmed: 25922503
Biofactors. 2017 Jul 8;43(4):577-592
pubmed: 28543688
Diabetes Metab. 2000 Nov;26(5):387-92
pubmed: 11119018
Curr Diab Rep. 2017 Aug;17(8):63
pubmed: 28695383
Mol Cell Biol. 2005 Oct;25(19):8520-30
pubmed: 16166634
Fluids Barriers CNS. 2012 Nov 09;9(1):23
pubmed: 23140302
Mol Cell Biochem. 2017 Sep;433(1-2):103-112
pubmed: 28378130
J Stroke Cerebrovasc Dis. 2012 May;21(4):293-8
pubmed: 21296593
Free Radic Biol Med. 2017 Jan;102:133-148
pubmed: 27890722
Circ Res. 2007 Apr 27;100(8):1128-41
pubmed: 17463328
Cardiovasc Diabetol. 2017 Apr 20;16(1):52
pubmed: 28427390
J Physiol. 2012 Jul 15;590(14):3349-60
pubmed: 22586215
Antioxid Redox Signal. 2014 Apr 1;20(10):1599-617
pubmed: 23581847
Curr Pharm Des. 2008;14(16):1594-600
pubmed: 18673200
Circ Res. 2013 Apr 12;112(8):1171-88
pubmed: 23580773
Front Physiol. 2014 May 06;5:175
pubmed: 24834056
Diabetes Metab. 2012 Apr;38(2):171-8
pubmed: 22349032
Endocr Metab Immune Disord Drug Targets. 2012 Jun;12(2):148-58
pubmed: 22236022
Brain Res. 1986 Feb 26;366(1-2):300-6
pubmed: 3697685
Curr Pharm Des. 2020;26(13):1438-1447
pubmed: 32209037
Biochemistry. 2015 May 19;54(19):3051-62
pubmed: 25915793
Microvasc Res. 2009 Jan;77(1):53-63
pubmed: 19028505
Mech Ageing Dev. 2013 Oct;134(10):506-15
pubmed: 24012632
Eur J Cell Biol. 2005 Jul;84(7):687-97
pubmed: 16106912
Ann Pharm Fr. 2014 Nov;72(6):400-8
pubmed: 25438650
Cell Mol Neurobiol. 2000 Apr;20(2):217-30
pubmed: 10696511
J Lab Clin Med. 2003 Apr;141(4):242-9
pubmed: 12677169
Biochimie. 2011 Apr;93(4):645-58
pubmed: 21167901
Can J Diabetes. 2015 Feb;39(1):44-9
pubmed: 25065473
Clin Sci (Lond). 1996 Apr;90(4):255-60
pubmed: 8777831
Methods Enzymol. 2014;542:243-62
pubmed: 24862270
Ann Neurol. 1977 May;1(5):409-17
pubmed: 617259
Circ Res. 2010 Oct 29;107(9):1058-70
pubmed: 21030723
Free Radic Res. 2019 Feb;53(2):150-169
pubmed: 30821539
Arch Biochem Biophys. 2018 Jun 1;647:54-66
pubmed: 29444458
Micromachines (Basel). 2019 Aug 13;10(8):
pubmed: 31412604
J Am Heart Assoc. 2017 Jun 1;6(6):
pubmed: 28572280
J Mol Endocrinol. 2016 Jan;56(1):23-37
pubmed: 26581238
Neurobiol Aging. 2013 Jul;34(7):1902-12
pubmed: 23428182
Cell Death Dis. 2014 Apr 10;5:e1172
pubmed: 24722297
Biochem Biophys Res Commun. 2002 Mar 1;291(3):669-74
pubmed: 11855842
Clin Chim Acta. 2002 Jul;321(1-2):89-96
pubmed: 12031597
J Pharmacovigil. 2014 Jun;2(2):125
pubmed: 25632404
Biochim Biophys Acta. 2012 May;1822(5):822-9
pubmed: 22206999
Microvasc Res. 2004 Nov;68(3):231-8
pubmed: 15501242
Arch Biochem Biophys. 2003 Nov 1;419(1):25-30
pubmed: 14568005
Biochim Biophys Acta Mol Basis Dis. 2017 May;1863(5):1037-1045
pubmed: 27156888
World J Diabetes. 2016 Sep 15;7(17):412-22
pubmed: 27660698
Biol Pharm Bull. 2013;36(3):492-5
pubmed: 23449334
Diabetologia. 2007 Jan;50(1):202-11
pubmed: 17143608
BMC Complement Altern Med. 2013 Jul 21;13:187
pubmed: 23870286

Auteurs

Anthony Dobi (A)

Inserm, UMR 1188 Diabète Athérothrombose Thérapies Réunion Océan Indien (DéTROI), plateforme CYROI, 97490 Sainte-Clotilde, France; Université de La Réunion, UMR 1188, 97490 Sainte-Clotilde, France.

Sarah Rosanaly (S)

Inserm, UMR 1188 Diabète Athérothrombose Thérapies Réunion Océan Indien (DéTROI), plateforme CYROI, 97490 Sainte-Clotilde, France; Université de La Réunion, UMR 1188, 97490 Sainte-Clotilde, France.

Anne Devin (A)

CNRS, Institut de Biochimie et Génétique Cellulaires, UMR 5095, Université de Bordeaux, F-33000 Bordeaux, France.

Pascal Baret (P)

Inserm, UMR 1188 Diabète Athérothrombose Thérapies Réunion Océan Indien (DéTROI), plateforme CYROI, 97490 Sainte-Clotilde, France; Université de La Réunion, UMR 1188, 97490 Sainte-Clotilde, France.

Olivier Meilhac (O)

Inserm, UMR 1188 Diabète Athérothrombose Thérapies Réunion Océan Indien (DéTROI), plateforme CYROI, 97490 Sainte-Clotilde, France; Université de La Réunion, UMR 1188, 97490 Sainte-Clotilde, France; CHU de La Réunion, Centre d'Investigation Clinique, 97400 Saint-Denis, France.

G Jean Harry (GJ)

Neurotoxicology Group, National Toxicology Program Laboratory, National Institute of Environmental Health Sciences, 27709 Research Triangle Park, NC, USA.

Christian Lefebvre d'Hellencourt (CL)

Inserm, UMR 1188 Diabète Athérothrombose Thérapies Réunion Océan Indien (DéTROI), plateforme CYROI, 97490 Sainte-Clotilde, France; Université de La Réunion, UMR 1188, 97490 Sainte-Clotilde, France; Neurotoxicology Group, National Toxicology Program Laboratory, National Institute of Environmental Health Sciences, 27709 Research Triangle Park, NC, USA. Electronic address: christian.lefebvre-d-hellencourt@univ-reunion.fr.

Philippe Rondeau (P)

Inserm, UMR 1188 Diabète Athérothrombose Thérapies Réunion Océan Indien (DéTROI), plateforme CYROI, 97490 Sainte-Clotilde, France; Université de La Réunion, UMR 1188, 97490 Sainte-Clotilde, France. Electronic address: rophil@univ-reunion.fr.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH